追加説明:
Shenzhen Haorui Industrial Dev. Co., Ltd. supplies Irinotecan HCl, an oncology API in the antineoplastic therapeutic category. Regulatory status includes USDMF No. 23522, US FDA approval, and CEP R0-CEP 2020-025 Rev 00, with stability data available for Zone IVB and WC. Contact the supplier for further details.
評価とコメントを残す